Delivery Order SPE2DB20D2104-SPE2DB26FMAHL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, on July 24, 2025, for the supply of Viberzi 100 mg tablets (60-count). This firm fixed price delivery order, valued at $1,184.87, is classified as a non-set-aside contract and is expected to reach ultimate completion by July 25, 2025, with performance occurring at AmerisourceBergen's Conshohocken...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Viberzi 75 mg tablets (60 count) valued at $2,354.21. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Viberzi 100 mg tablets (60-count units) valued at $1,325.08. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,881.75 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,960.49 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on July 15, 2025, with completion scheduled for July 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.84 for VIBERZI 100 mg tablets (60-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100mg, with a ceiling value of $2,276.80. This competitive award, effective August 12, 2025, with an ultimate completion date of August 13, 2025, was executed under firm fixed-price terms with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a $1,452.50 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viberzi 75 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award derives from the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) valued at $3,764.82 with a firm fixed price structure. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Viberzi 100 mg tablets (60-count), a pharmaceutical product with a contract ceiling value of $1,761.21. This non-set-aside, competitively awarded delivery order represents a firm fixed price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAHLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,707.60 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) with a firm fixed price and an ultimate completion date of October 20, 2025. This non-set-aside competitive award was issued on October 17, 2025, with performance to be fulfilled at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion pharmaceutical prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor headquartered in Pennsylvania, specializing in the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contract awards demonstrates its capability to meet diverse medical supply procurement requirements through open competition, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Viberzi, a gastrointestinal medication, reflects the company's ongoing role in supporting military and federal healthcare operations through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/17/25 |